Summit Therapeutics
SMMT
$3.95
Share price
2.33%
Change (1 day)
199.24%
Change (1 year)
Categories
Summit Therapeutics (SMMT) - Net assets
Net assets on the balance sheet as of December 2023 : $77.69 M
According to Summit Therapeutics
's latest financial reports the company has $77.69 M in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Summit Therapeutics - Net assets on balance sheet (from 2020 to 2020)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2023-12-31 | $77.69 M | -38.66% |
| 2022-12-31 | $0.12 B | 52.07% |
| 2021-12-31 | $83.28 M | 4.82% |
| 2020-12-31 | $79.45 M | |
| 2019-01-31 | $73.18 M | -1258.7% |
| 2018-01-31 | $-6.32 M | 15.72% |
| 2017-01-31 | $-5.46 M | -116.73% |
| 2016-01-31 | $32.62 M | 10.72% |
| 2015-01-31 | $29.46 M | 127.36% |
| 2014-01-31 | $12.95 M | 82.17% |
| 2013-01-31 | $7.11 M | 19.87% |
| 2012-01-31 | $5.93 M | -35.58% |
| 2011-01-31 | $9.21 M | -56.33% |
| 2010-01-31 | $21.09 M | 20.42% |
| 2009-01-31 | $17.51 M | -83.73% |
| 2008-01-31 | $0.10 B | 36.69% |
| 2007-01-31 | $78.75 M | 89.43% |
| 2006-01-31 | $41.57 M | -16.82% |
| 2005-01-31 | $49.98 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Sarepta Therapeutics
SRPT | $0.85 B | 1,006.08% | 🇺🇸 USA |
 Merrimack Pharmaceuticals MACK | $18.74 M | -75.87% | 🇺🇸 USA |
 Coherus BioSciences
CHRS | -$0.2 B | -348.96% | 🇺🇸 USA |